Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1988 3
1989 1
1991 3
1992 3
1993 6
1994 4
1995 5
1996 7
1997 6
1998 4
1999 3
2000 4
2001 2
2002 4
2003 7
2004 8
2005 9
2006 7
2007 13
2008 8
2009 6
2010 7
2011 5
2012 14
2013 6
2014 4
2015 10
2016 12
2017 6
2018 8
2019 5
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Results by year
Filters applied: . Clear all
Page 1
Rosuvastatin use improves measures of coagulation in patients with venous thrombosis.
Biedermann JS, Kruip MJHA, van der Meer FJ, Rosendaal FR, Leebeek FWG, Cannegieter SC, Lijfering WM. Biedermann JS, et al. Among authors: van der Meer FJ. Eur Heart J. 2018 May 14;39(19):1740-1747. doi: 10.1093/eurheartj/ehy014. Eur Heart J. 2018. PMID: 29394348 Clinical Trial.
Home treatment of patients with cancer-associated venous thromboembolism - An evaluation of daily practice.
Hendriks SV, Huisman MV, Eikenboom JCJ, Fogteloo J, Gelderblom H, van der Meer FJM, Stenger WJE, Verschoor AJ, Versteeg HH, Klok FA. Hendriks SV, et al. Among authors: van der Meer FJM. Thromb Res. 2019 Dec;184:122-128. doi: 10.1016/j.thromres.2019.10.031. Epub 2019 Nov 4. Thromb Res. 2019. PMID: 31731069 Free article.
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study.
Zielinski GD, van Rein N, Teichert M, Klok FA, Rosendaal FR, van der Meer FJM, Huisman MV, Cannegieter SC, Lijfering WM. Zielinski GD, et al. Among authors: van der Meer FJM. Res Pract Thromb Haemost. 2019 Oct 24;4(1):141-153. doi: 10.1002/rth2.12261. eCollection 2020 Jan. Res Pract Thromb Haemost. 2019. PMID: 31989096 Free PMC article.
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
Orsi FA, Biedermann JS, Kruip MJHA, van der Meer FJ, Rosendaal FR, van Hylckama Vlieg A, Bos MHA, Leebeek FWG, Cannegieter SC, Lijfering WM. Orsi FA, et al. Among authors: van der Meer FJ. J Thromb Haemost. 2019 Feb;17(2):319-328. doi: 10.1111/jth.14364. Epub 2019 Feb 3. J Thromb Haemost. 2019. PMID: 30565854 Free PMC article. Clinical Trial.
Persistence to direct oral anticoagulants for acute venous thromboembolism.
Dronkers CEA, Lijfering WM, Teichert M, van der Meer FJM, Klok FA, Cannegieter SC, Huisman MV. Dronkers CEA, et al. Among authors: van der Meer FJM. Thromb Res. 2018 Jul;167:135-141. doi: 10.1016/j.thromres.2018.05.013. Epub 2018 May 19. Thromb Res. 2018. PMID: 29843087
Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery.
Preijers T, Hazendonk HCAM, Liesner R, Chowdary P, Driessens MHE, Hart D, Keeling D, Laros-van Gorkom BAP, van der Meer FJM, Meijer K, Fijnvandraat K, Leebeek FWG, Collins PW, Cnossen MH, Mathôt RAA; OPTI‐CLOT study group. Preijers T, et al. Among authors: van der Meer FJM. J Thromb Haemost. 2018 Nov;16(11):2196-2207. doi: 10.1111/jth.14292. Epub 2018 Oct 28. J Thromb Haemost. 2018. PMID: 30394056 Clinical Trial.
The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study.
Maagdenberg H, Bierings MB, van Ommen CH, van der Meer FJM, Appel IM, Tamminga RYJ, le Cessie S, Swen JJ, van der Straaten T, de Boer A, Maitland-van der Zee AH. Maagdenberg H, et al. Among authors: van der Meer FJM. J Thromb Haemost. 2018 Sep;16(9):1732-1742. doi: 10.1111/jth.14211. Epub 2018 Jul 17. J Thromb Haemost. 2018. PMID: 29935043 Clinical Trial.
Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort.
Maagdenberg H, Bierings MB, van Ommen CH, van der Meer FJM, Appel IM, Tamminga RYJ, de Boer A, Maitland-van der Zee AH. Maagdenberg H, et al. Among authors: van der Meer FJM. J Thromb Haemost. 2018 Jan;16(1):116-124. doi: 10.1111/jth.13897. Epub 2017 Nov 23. J Thromb Haemost. 2018. PMID: 29108090 Free article. Clinical Trial.
Perioperative replacement therapy in haemophilia B: An appeal to "B" more precise.
Hazendonk HCAM, Preijers T, Liesner R, Chowdary P, Hart D, Keeling D, Driessens MHE, Laros-van Gorkom BAP, van der Meer FJM, Meijer K, Fijnvandraat K, Leebeek FWG, Mathôt RAA, Collins PW, Cnossen MH. Hazendonk HCAM, et al. Among authors: van der Meer FJM. Haemophilia. 2018 Jul;24(4):611-618. doi: 10.1111/hae.13469. Epub 2018 Apr 29. Haemophilia. 2018. PMID: 29707861
Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients.
Maagdenberg H, Bierings MB, van Ommen CH, van der Meer FJ, Appel IM, Tamminga RY, Cessie SL, Swen JJ, der Straaten TV, Boer A, Maitland-van der Zee AH. Maagdenberg H, et al. Among authors: van der Meer FJ. Pharmacogenomics. 2018 Oct;19(15):1195-1202. doi: 10.2217/pgs-2018-0095. Epub 2018 Sep 12. Pharmacogenomics. 2018. PMID: 30207196
190 results
Jump to page
Feedback